Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
APO-Gabapentin Capsules CMI 28 Mar 2017
APO-Gabapentin Capsules PI 28 Mar 2017
Zidoval PI 28 Mar 2017
Benlysta PI 28 Mar 2017
Postella-1 PI 28 Mar 2017

New products

Product name Type Date released
Brenzys CMI 28 Mar 2017
Alecensa CMI 28 Mar 2017
Alecensa PI 28 Mar 2017
APO-Olmesartan HCTZ PI 27 Mar 2017
APO-Olmesartan HCTZ CMI 27 Mar 2017